Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

The association between telomere length and cancer risk in population studies.

Zhu X, Han W, Xue W, Zou Y, Xie C, Du J, Jin G.

Sci Rep. 2016 Feb 26;6:22243. doi: 10.1038/srep22243.

2.

Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsy.

Bodelon C, Heaphy CM, Meeker AK, Geller B, Vacek PM, Weaver DL, Chicoine RE, Shepherd JA, Mahmoudzadeh AP, Patel DA, Brinton LA, Sherman ME, Gierach GL.

BMC Cancer. 2015 Oct 30;15:823. doi: 10.1186/s12885-015-1860-2.

3.

Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors.

Duggan C, Risques R, Alfano C, Prunkard D, Imayama I, Holte S, Baumgartner K, Baumgartner R, Bernstein L, Ballard-Barbash R, Rabinovitch P, McTiernan A.

J Natl Cancer Inst. 2014 Apr;106(4):dju035. doi: 10.1093/jnci/dju035. Epub 2014 Mar 13.

4.

Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.

Pellatt AJ, Wolff RK, Torres-Mejia G, John EM, Herrick JS, Lundgreen A, Baumgartner KB, Giuliano AR, Hines LM, Fejerman L, Cawthon R, Slattery ML.

Genes Chromosomes Cancer. 2013 Jul;52(7):595-609. doi: 10.1002/gcc.22056. Epub 2013 Apr 30.

5.

Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.

Lyon D, Elmore L, Aboalela N, Merrill-Schools J, McCain N, Starkweather A, Elswick RK Jr, Jackson-Cook C.

Biol Res Nurs. 2014 Apr;16(2):160-74. doi: 10.1177/1099800413483545. Epub 2013 Apr 11.

6.

Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study.

Qu S, Wen W, Shu XO, Chow WH, Xiang YB, Wu J, Ji BT, Rothman N, Yang G, Cai Q, Gao YT, Zheng W.

Am J Epidemiol. 2013 Apr 1;177(7):617-24. doi: 10.1093/aje/kws291. Epub 2013 Feb 25.

7.

Is socioeconomic status associated with biological aging as measured by telomere length?

Robertson T, Batty GD, Der G, Fenton C, Shiels PG, Benzeval M.

Epidemiol Rev. 2013;35:98-111. doi: 10.1093/epirev/mxs001. Epub 2012 Dec 20. Review.

8.

Genetic variation in telomere maintenance genes, telomere length and breast cancer risk.

Shen J, Terry MB, Liao Y, Gurvich I, Wang Q, Senie RT, Santella RM.

PLoS One. 2012;7(9):e44308. doi: 10.1371/journal.pone.0044308. Epub 2012 Sep 6.

9.

Is telomere length socially patterned? Evidence from the West of Scotland Twenty-07 Study.

Robertson T, Batty GD, Der G, Green MJ, McGlynn LM, McIntyre A, Shiels PG, Benzeval M.

PLoS One. 2012;7(7):e41805. doi: 10.1371/journal.pone.0041805. Epub 2012 Jul 23.

10.

Genetic anticipation is associated with telomere shortening in hereditary breast cancer.

Martinez-Delgado B, Yanowsky K, Inglada-Perez L, Domingo S, Urioste M, Osorio A, Benitez J.

PLoS Genet. 2011 Jul;7(7):e1002182. doi: 10.1371/journal.pgen.1002182. Epub 2011 Jul 28.

11.

Epidemiologic evidence for a role of telomere dysfunction in cancer etiology.

Prescott J, Wentzensen IM, Savage SA, De Vivo I.

Mutat Res. 2012 Feb 1;730(1-2):75-84. doi: 10.1016/j.mrfmmm.2011.06.009. Epub 2011 Jul 2. Review.

12.

Shortened telomere length is associated with increased risk of cancer: a meta-analysis.

Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning AM, Svenson U, Roos G, Hosgood HD 3rd, Shen M, Wei Q.

PLoS One. 2011;6(6):e20466. doi: 10.1371/journal.pone.0020466. Epub 2011 Jun 10.

13.

Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: results from the Sister Study.

Kim S, Sandler DP, Carswell G, De Roo LA, Parks CG, Cawthon R, Weinberg CR, Taylor JA.

Cancer Causes Control. 2011 Jul;22(7):1061-6. doi: 10.1007/s10552-011-9778-8. Epub 2011 Jun 5.

14.

Telomere length and variation in telomere biology genes in individuals with osteosarcoma.

Mirabello L, Richards EG, Duong LM, Yu K, Wang Z, Cawthon R, Berndt SI, Burdett L, Chowdhury S, Teshome K, Douglass C, Savage SA; National Osteosarcoma Etiology Study Group.

Int J Mol Epidemiol Genet. 2011 Jan 1;2(1):19-29. Epub 2010 Nov 23.

15.

The association of telomere length and cancer: a meta-analysis.

Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1238-50. doi: 10.1158/1055-9965.EPI-11-0005. Epub 2011 Apr 5.

16.

The potential utility of telomere-related markers for cancer diagnosis.

Heaphy CM, Meeker AK.

J Cell Mol Med. 2011 Jun;15(6):1227-38. doi: 10.1111/j.1582-4934.2011.01284.x. Review.

17.

Telomere deficiencies on chromosomes 9p, 15p, 15q and Xp: potential biomarkers for breast cancer risk.

Zheng YL, Zhou X, Loffredo CA, Shields PG, Sun B.

Hum Mol Genet. 2011 Jan 15;20(2):378-86. doi: 10.1093/hmg/ddq461. Epub 2010 Oct 18.

18.

Telomere length in prospective and retrospective cancer case-control studies.

Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN, Bingham SA, Ponder BA, Pharoah PD, Khaw KT, Easton DF, Dunning AM.

Cancer Res. 2010 Apr 15;70(8):3170-6. doi: 10.1158/0008-5472.CAN-09-4595.

19.

Chromosome 9 arm-specific telomere length and breast cancer risk.

Zheng YL, Loffredo CA, Shields PG, Selim SM.

Carcinogenesis. 2009 Aug;30(8):1380-6. doi: 10.1093/carcin/bgp151. Epub 2009 Jun 17.

Items per page

Supplemental Content

Write to the Help Desk